Signal Transduction and Targeted Therapy

Metadata for this journal is being automatically enriched from connected scholarly data sources.

Journal information

Publisher

Nature Portfolio

Subjects

Biology (General) · Cancer Immunotherapy and Biomarkers · CAR-T cell therapy research · cell biology · computational chemistry · COVID-19 Clinical Research Studies · Epigenetics and DNA Methylation · Immune Cell Function and Interaction · Immune cells in cancer · medicinal chemistry · Medicine · molecular biology · pharmacology · R · RNA modifications and cancer · SARS-CoV-2 and COVID-19 Research · systems biology

Country

GB

Languages

EN

ISSN

—

E-ISSN

2059-3635

ISSN-L

2059-3635

Open access

Yes

OA since

2016

Publication years

1975–2026

APC (summary)

—

Website

Visit journal ↗

Journal Classification

Classification is derived from this journal’s 2024–2025 publications using the OpenAlex taxonomy.

Classification

Field / Subfield

Primary Field

Medicine

Primary Subfield

Oncology

Domain

Health Sciences

Confidence

Medium

Publications classified

797

Classification version

OAJF Classification v1.1

APC records

OPENALEX · 2026

3,090 EUR

OPENALEX · 2026

2,790 GBP

OPENALEX · 2026

3,790 USD

DOAJ · 2026

3,390 EUR

DOAJ · 2026

3,090 GBP

DOAJ · 2026

4,170 USD